Reduced p27 protein expression is frequently observed in human tumors such as breast, colorectal, prostate, head and neck, lung and gastric cancers, leukemia, lymphoma, neuroblastoma and melanoma, and is often a bad prognostic factor in these diseases [26–28]. Here, CDKN1B is linked to neuroblastoma.